Your browser doesn't support javascript.
loading
Beneath the surface: a case report of metastatic iridociliary ring melanoma treated with pembrolizumab.
Parra-Bernal, Cinthya; Aguilera-Partida, Jorge A; Dalvin, Lauren A; Rodríguez-Reyes, Abelardo A; Ancona-Lezama, David.
Afiliação
  • Parra-Bernal C; Ocular Oncology Service, Institute of Ophthalmology and Visual Sciences, Tecnologico de Monterrey, Monterrey, Mexico.
  • Aguilera-Partida JA; Uveitis and Ocular Inflammation Service, Clínica Oftalmológica Santa Lucía, Guadalajara, Jalisco, Mexico.
  • Dalvin LA; Department of Ophthalmology, Mayo Clinic, Rochester, Minnesota, United States.
  • Rodríguez-Reyes AA; Ophthalmic Pathology Service, Asociación Para Evitar La Ceguera en México, Hospital Dr. Luis Sanchez Bulnes, Mexico City, Mexico.
  • Ancona-Lezama D; Ocular Oncology Service, Institute of Ophthalmology and Visual Sciences, Tecnologico de Monterrey, Monterrey, Mexico.
Arq Bras Oftalmol ; 2022 Mar 21.
Article em En | MEDLINE | ID: mdl-35319657
ABSTRACT
Iridociliary ring melanoma is an uncommon type of uveal melanoma. Clinical manifestation varies from asymptomatic cases to masquerade syndromes mimicking refractory glaucoma. Treatment options include radiotherapy and enucleation. Management of metastatic uveal melanoma remains discouraging. Novel therapies using immune checkpoint inhibitors are currently under study. We present a case of a 54-year-old Hispanic woman with progressive vision loss due to metastatic ring melanoma with anterior chamber seeding treated with pembrolizumab.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Arq Bras Oftalmol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Arq Bras Oftalmol Ano de publicação: 2022 Tipo de documento: Article